A critique of hypertension treatment trials and of their evaluation

This publication has 96 references indexed in Scilit:

• Uses of error: clinical and epidemiological
  The Lancet, 2001
• Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials
  The Lancet, 2000
• Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)
  The Lancet, 2000
• Do alpha blockers cause heart failure and stroke? Observations from ALLHAT
  Journal of Human Hypertension, 2000
• Effect of risk status on treatment criteria. Implications of hypertension trials.
  Hypertension, 1989
• Incidence of coronary heart disease and left ventricular hypertrophy in the Hypertension Detection and Follow-up Program
  Progress in Cardiovascular Diseases, 1986
• MORTALITY AND MORBIDITY RESULTS FROM THE EUROPEAN WORKING PARTY ON HIGH BLOOD PRESSURE IN THE ELDERLY TRIAL*1, *2
  The Lancet, 1985
• Relation of Arterial Pressure with Body Sodium, Body Potassium and Plasma Potassium in Essential Hypertension
  Clinical Science, 1982
• Control of Moderately Raised Blood Pressure: REPORT OF A CO-OPERATIVE RANDOMIZED TRIAL
  BMJ, 1973
• HYPOTENSIVE THERAPY IN STROKE SURVIVORS
  The Lancet, 1970